Home
Genfit

Genfit Market Share Analysis for July 2026

Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma Investigational drug GNS561 showed a

Health > Biotechnology and Pharmaceuticals

Domaingenfit.com

Year Founded1999

Employees51 - 200

Annual Revenue$50M - $75M

Genfit

Genfit (including company regionals)

genfit.com

See more website traffic and engagement information

Genfit Revenue up to July 2026 is 50M - 75M

revenue generated by Genfit top domains

Genfit top domains revenue over 3 years

Revenue for Genfit top domains

genfit.com50M - 75M

See more with Sales Intelligence

Total visits to Genfit's top domains

Understand Genfit market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

genfit.com7.9K

See more with Sales Intelligence

Avg. visit duration in Genfit's top domains

Analyze Genfit engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

genfit.com00:01:12

See more with Sales Intelligence

Avg. pageviews on Genfit's top domains

See how Genfit keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

genfit.com2.55

See more with Sales Intelligence

Genfit top competitors by domain

Top similar sites in July 2026, ranked by their affinity

xencor.comCompany NameXencorEmployees201 - 500HQUnited States, California, MonroviaAnnual revenue$100M - $200MTotal visits6.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Genfit

These are the website technologies, by industry, used by Genfit top domains

Conversion & Analytics (8)

Google Analytics

Widget (5)

Twemoji

Social (4)

AddThis

Advertising (3)

Google Adsense

More Technologies

11

See all

News & Signals from Genfit

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenfit Sa acquires Araris Biotech AG.The 10 startups will follow in the footsteps of high-flying former team members such as Araris Biotech (recently announced its acquisition for USD 1.1 billion), Covagen (acquired by Johnson & Johnson), Versantis (acquired by Genfit), AMAL Therapeutics (acquired by Boehringer Ingelheim), NBE-Therapeutics (acquired by Boehringer Ingelheim), Alentis (USD 105 million funding round in 2023), and BioVersys (recent IPO on the SIX Swiss Exchange).

NewsGenfit Sa attends event The Liver Meeting(R) 2025.GENFIT presents promising new preclinical data on NTZ/G1090N for the treatment of ACLF at The Liver Meeting(R) 2025.

NewsGenfit Sa partners with Everzom.Genfit SA has established a research collaboration with Everzom SAS to expand its acute-on-chronic liver failure (ACLF) research via exosome-based regenerative technology.